An Improved YOLO-SCS Model for AQP4 Antibody Immunofluorescence Image Detection
Mozi · 01.01.2026 · 1 (Mozi) · 15
DOI: 10.66535/myw05225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mozi, online erschienen am 01.01.2026. Verfasst von Xiaoyao Wu und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Neuromyelitis optica spectrum disorder (NMOSD) diagnosis currently relies on the cell-based assay (CBA) as the gold standard for detecting aquaporin-4 (AQP4) antibodies. However, manual interpretation of AQP4 antibody immunofluorescence images is subjective, time-consuming, and prone to variability. These images often exhibit challenges such as small, densely distributed positive signals, weak fluorescence intensity, and severe background interference from non-specific binding or artifacts.To address these issues, we propose an improved YOLO-based model, termed YOLO-SCS, built upon YOLOv11, for accurate detection of positive signals in AQP4 immunofluorescence images. First, a high-quality dataset of AQP4 immunofluorescence images was constructed with precise annotations. A Gaussian Peak-optimized Channel Adjustment (GPCA) algorithm was designed for preprocessing to enhance weak fluorescence contrast while effectively suppressing background noise. On the YOLOv11 architecture, we incorporated the SPD-Conv module in the downsampling stages to preserve fine-grained spatial features critical for small targets. Additionally, a shape-aware Normalized Wasserstein Distance (NWD) loss function was adopted to improve bounding box regression accuracy for densely overlapping and irregularly shaped positive regions. Experimental evaluations on a clinically representative dataset (positive-to-negative ratio of 1:9) demonstrated superior performance: the proposed YOLO-SCS achieved a positive detection rate of 98.4%, negative specificity of 100%, mAP@0.5 of 0.6971, and mAP@0.5:0.95 of 0.4256. These metrics significantly outperform the baseline YOLOv11 and other state-of-the-art improved models. The model reliably distinguishes specific positive fluorescence signals from background impurities, providing robust automated interpretation support for AQP4 immunofluorescence in NMOSD clinical diagnosis and potentially reducing diagnostic turnaround time and inter-observer variability.
Zitieren
APA
Wu, X., Yin, P., & Shi, L. (2026). An Improved YOLO-SCS Model for AQP4 Antibody Immunofluorescence Image Detection. Mozi, 1(Mozi), 15. https://doi.org/10.66535/myw05225
Vancouver
Wu X, Yin P, Shi L. An Improved YOLO-SCS Model for AQP4 Antibody Immunofluorescence Image Detection. Mozi. 2026;1(Mozi):15. doi:10.66535/myw05225
BibTeX
@article{Wu2026,
author = {Wu, Xiaoyao and Yin, Pengju and Shi, Longkuan},
title = {An Improved YOLO-SCS Model for AQP4 Antibody Immunofluorescence Image Detection},
journal = {Mozi},
year = {2026},
volume = {1},
number = {Mozi},
pages = {15},
doi = {10.66535/myw05225}
}
EUVIMED